In this context, we found that spontaneous NETs released in the recruited groups of patients, as well as the increase in the activation markers CD11b and CD66b of neutrophils, were associated with the time to diagnose T2DM. This evidence concerns the gene CEACAM8 and type 2 diabetes mellitus.